IGFBP3 and non-small cell lung carcinoma: IGFBP-3 knockout was shown to promote lung tumorigenesis while IGFBP-3 overexpression led to increased apoptosis, decreased cell growth, and increased susceptibility of NSCLC cell lines to cisplatin treatment [49,91].